Related Experiment Videos
Persistent inhibition of neutrophil function by glucose based dialysis solutions
Summary
Continuous ambulatory peritoneal dialysis (CAPD) solutions at pH 5.2 impair neutrophil function, including actin polymerization and phagocytosis. This inhibition persists even after pH adjustment, indicating a cytotoxic effect on immune cells.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Peritonitis is a major complication of continuous ambulatory peritoneal dialysis (CAPD).
- Local defense mechanisms, particularly polymorphonuclear neutrophils (PMN), are crucial for preventing peritonitis.
- Standard glucose-based dialysis solutions (GBDS) have an acidic pH that can affect PMN function.
Purpose of the Study:
- To investigate if the inhibitory effects of acidic CAPD solutions on PMN cytoskeletal function and intracellular pH are reversible upon pH adjustment.
- To assess the impact of commercially available GBDS at pH 5.2 and pH 6.4 on PMN actin polymerization, phagocytosis, and intracellular pH in vitro.
Main Methods:
- Human PMN were isolated and incubated with GBDS at pH 5.2 and pH 6.4.
- Actin polymerization was measured using NBD phallacidin staining and flow cytometry.
- Phagocytosis was assessed using zymosan particles.
- Intracellular pH was monitored using spectrofluorometry.
Main Results:
- Incubation with GBDS at pH 5.2 caused persistent inhibition of actin polymerization and phagocytosis in PMN.
- Adjusting the pH of the GBDS to 6.4 did not fully reverse the inhibition of cytoskeletal function or phagocytosis.
- Intracellular acidosis in PMN was not resolved by pH adjustment of the dialysis solution.
Conclusions:
- Acidic CAPD solutions exert a persistent cytotoxic effect on human phagocytes, impairing essential immune functions.
- Current GBDS formulations may compromise the local defense mechanisms in the peritoneal cavity.
- Modification of CAPD solutions to achieve a more physiologic pH is recommended to support optimal phagocyte function and potentially reduce peritonitis risk.